home / stock / fbio / fbio articles

FBIO Articles, Fortress Biotech Inc. - From 01/02/24

Stock Information
Company Name: Fortress Biotech Inc.
Stock Symbol: FBIO
Market: NASDAQ
Website: fortressbiotech.com
Menu
FBIO FBIO Quote FBIO Short FBIO News FBIO Articles FBIO Message Board
Get FBIO Alerts

News, Short Squeeze, Breakout and More Instantly...
Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million | Benzinga

SCOTTSDALE, Ariz., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (NASDAQ:DERM) ("Journey Medical" or "the Company"), a commercia...
Fear & Greed Index Remains In 'Extreme Greed' Zone; S&P 500 Surges 24% In 2023 | Benzinga

The CNN Money Fear and Greed index showed some decline in overall market sentiment, but the index remained in the "Extreme Greed" zone on...

Gold Moves Lower; Microbot Medical Shares Slide | Benzinga

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 50 points on Friday. The Dow traded down 0.17% to 37...

Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session | Benzinga

Shares of Fisker Inc. (NYSE: FSR) rose sharply during Friday’s session after the company provided a December 2023 business update. The compa...
Nasdaq Down Over 100 Points; Fortress Biotech Shares Plummet | Benzinga

U.S. stocks turned lower midway through trading, with the Nasdaq Composite falling more than 100 points on Friday. The Dow traded down 0.34% to 37,...

Why Fortress Biotech Shares Are Tumbling Today | Benzinga

Fortress Biotech Inc (NASDAQ: FBIO) shares are trading lower by over 18% after it announced the pricing of a $11 million registered direc...

Fortress Biotech Announces Pricing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules | Benzinga

MIAMI, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ:FBIO) ("Fortress" or "Company"), an innovative biopharmaceutical company...
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline...

Checkpoint Therapeutics Strengthens Intellectual Property Protection for Cosibelimab with New U.S. Patent Issuance | Benzinga

Upcoming PDUFA goal date of January 3, 2024 U.S. patent protection for cosibelimab through at least May 2038 WALTHAM, Mass., Dec. 05, 2023 (GLOB...

Avenue Therapeutics to Present at American Epilepsy Society 2023 Annual Meeting | Benzinga

MIAMI, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ:ATXI) ("Avenue" or the "Company"), a specialty pharmaceutical company...
Previous 10 Next 10